Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Alrosa expects growth in demand for rough and polished diamond products

11/14/23 ALRS

Gazprom is building a new de-ethanization unit at the Urengoy Plant

11/14/23 GAZP

Fesco intends to become a major sovereign logistics operator

11/14/23 FESH

Fesco reported for 9 months of 2023 by RAS

11/14/23 FESH

CarMoney is set to make ₽2 billion in profits

11/14/23 CARM

Ozon entered Uzbekistan market

11/14/23 OZON

Tinkoff Bank reported for 9 months of 2023 by RAS

11/14/23 T

Gazprom Neft reports for 9 months of 2023 by RAS

11/14/23 SIBN

Pharmsintez may conduct additional share issue

11/13/23 LIFE

Board of Directors of Artgen Biotech decided the issue of additional share issue itself

11/13/23 ABIO